Virginia Retirement Systems’s Amneal Pharmaceuticals AMRX Stock Holding History

Virginia Retirement Systems’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$180K	Buy	+10,400	New	+$143K	﹤0.01%	1267
2023 Q1	–	Sell	-130,200	Closed	-$259K	–	1041
2022 Q4	$259K	Hold	130,200	–	–	﹤0.01%	1008
2022 Q3	$263K	Buy	+130,200	New	+$365K	﹤0.01%	983
2022 Q1	$628K	Buy	150,600 +300	+0.2%	+$1.33K	0.01%	788
2021 Q4	$720K	Buy	150,300 +2,300	+2%	+$11.5K	﹤0.01%	753
2021 Q3	$790K	Sell	148,000 -11,300	-7%	-$56.9K	0.01%	677
2021 Q2	$816K	Buy	159,300 +42,800	+37%	+$243K	0.01%	715
2021 Q1	$784K	Buy	116,500 +76,200	+189%	+$422K	0.01%	740
2020 Q4	$184K	Buy	40,300 +29,600	+277%	+$131K	﹤0.01%	1065
2020 Q3	$42K	Buy	10,700 +700	+7%	+$2.99K	﹤0.01%	1070
2020 Q2	$48K	Buy	+10,000	New	+$41.2K	﹤0.01%	1077

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Virginia Retirement Systems's AMRX Position: Q2 2026 in Review

Virginia Retirement Systems opened a new position in Amneal Pharmaceuticals (AMRX) in Q2 2026: 10,400 shares worth $180K. The stake represents ﹤0.01% of the portfolio and ranks #1267 among its holdings. This is a return to the name: Virginia Retirement Systems previously reported a position in AMRX as recently as Q4 2022.

Virginia Retirement Systems first reported a position in AMRX in Q2 2020 and has held it in 11 quarters since. The position peaked at $816K in Q2 2021. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Virginia Retirement Systems held 10,400 shares of Amneal Pharmaceuticals worth $180K as of Q2 2026.
Amneal Pharmaceuticals was a new Virginia Retirement Systems position in Q2 2026.
Amneal Pharmaceuticals made up ﹤0.01% of Virginia Retirement Systems's portfolio in Q2 2026, its #1267 holding.
Virginia Retirement Systems first reported a position in Amneal Pharmaceuticals in Q2 2020 and has held it in 11 quarters since.
Virginia Retirement Systems's Amneal Pharmaceuticals position peaked at $816K in Q2 2021.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Virginia Retirement Systems's 13F filing for Q2 2026, filed 25 Aug 2026.